Fundamental deficiencies in the megatrial methodology
- PMID: 11806765
- PMCID: PMC59645
- DOI: 10.1186/cvm-2-1-002
Fundamental deficiencies in the megatrial methodology
Abstract
The fundamental methodological deficiency of megatrials is deliberate reduction of experimental control in order to maximize recruitment and compliance of subjects. Hence, typical megatrials recruit pathologically and prognostically heterogeneous subjects, and protocols typically fail to exclude significant confounders. Therefore, most megatrials do not test a scientific hypothesis, nor are they informative about individual patients. The proper function of a megatrial is precise measurement of effect size for a therapeutic intervention. Valid megatrials can be designed only when simplification can be achieved without significantly affecting experimental control. Megatrials should be conducted only at the end of a long process of therapeutic development, and must always be designed and interpreted in the context of relevant scientific and clinical information.
References
-
- Healy D. The Antidepressant Era Cambridge, MA: Harvard University Press, 1998.
-
- Charlton BG. The new management of scientific knowledge: a change in direction with profound implications. In NICE, CHI and the NHS Reforms: Enabling Excellence or Imposing Control? Edited by Miles A, Hampton JR, Hurwitz B London: Aesculapius Medical Press, 2000. pp. 13–32.
LinkOut - more resources
Full Text Sources
